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Abstract: 
 
Cancer  is  the   second  leading  cause  of  death  despite  the  anti  cancer  developments 
including  hormone  therapy,  radiotherapy,  chemotherapy. Chemotherapy  includes  use  of 
potent  drugs  such  as  camptothecin,  paclitaxel  and  mitomycin.  These  drugs  have  a  effect 
which  is  dose  responsive, where  the  drug  exposure  and  cell kill  are  proportional.  This 
chemotherapy  is  high  dose  and  has  less  selectivity  for  cancer  cells  and  has  more  toxic 
effect  to  normal  cells. Such  kind  of  non  specific  treatment  to  tumor  is  causing  hurdles  in 
the  treatment  of  cancer  by  chemotherapy.  To  overcome  this  current  limitation  to 
chemotherapy,  the  anti  cancer  drug  with  high  specificity  is  given  in  concentration 
effective  to  the  tumor  tissues. [1, 2][1, 2][1, 2]  In  order  to  achieve  this  goal,  tumor  
selective  drugs  were developed  by  conjugating  antibodies,  hormones  and  vitamin  
derivatives  to  anti  cancer drugs.  One  such  compound,  folic  acid,  which  is  low  molecular  
weight  vitamin,  has emerged  as  ligand  for  delivery  of  drugs  to  cancer  tissues. Since the 
folate receptors are over expressed in cancer cells, conjugation of anticancer drugs with folate 
serves as a highly effective way to treat cancer with fewer side effects. This way, the normal 
cells can be prevented from the toxic effects of the anticancer drugs. Hence, folate receptors can 
be used as a useful tool for selective targeting of drugs. [3] 
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Introduction: 
Folic Acid: 
 
Folate    plays    an    important  role  as  it  participates  in  the  biosynthesis  of  nucleic  and  
amino  acids  and  thus  is  essential  in  cell  survival. [4] It is   a   member of vitamin B family.  
Folate  is  used  to  enhance  the  differential  specificity  of  anticancer  drugs  as  it  targets  the  
folate  receptor  positive  cancer  cells.  By  this  property  it  serves  as  a  high  affinity  ligand. 
Conjugation  of  anticancer  drugs  to  folate  was  found  to  decrease  the  side  effects  and 
increase  the  drug  selectivity  .  FR  is  a   glycosylphosphatidylinositol  anchored  protein,  
which  is  associated  with  tumor.  It  can  internalize  the  folates  which  are  bound  and  
conjugated  compounds  bound  to  folate  via  receptor  mediated  endocytosis.  The  FR  density  
is  found  to  be  high  in  breast  carcinomas  and  low  levels  are  found  in  normal  tissues.  Its  
density  was  also  found  to  increase  as  the  cancer  progresses.  A wide  range  of  anti  cancer  
drugs  were  conjugated  and  evaluated  for  their  anti  cancer  activity  based  on  the  fact  that  
conjugation  of  folate  helps  in  targeting  the  drug  molecule  and  getting  endocytosed  into  
cells  with  positive  FR.  Such  drugs  include  EC  72  ,  EC  118  and  folate  mitomycin.  These  
were  found  to  have  selectivity  for  FR  positive  M109  cells.  When  these  E118  and  EC  72  
were  studied  in vivo  and  in vitro,  it  was  proved  that  drug  specificity  and  selectivity  was  
enhanced  by  folate  conjugation  more  over  reducing  the  toxicity. [1] 
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Folate Receptors: 
 
The  folate  receptor  was found to  have  two  isoforms  which  are  glycosyl  phoshatidylinositol  
(GPI)  anchored.  They are alpha and beta.  Epithelial  cancers  are  usually  associated  with  FR-  
alpha  expression  and  myeloid  leukemia  and  activated  macrophages  are  associated  with  
FR-  beta  expression.  The  targeted  delivery  to  FR+  cells  is  done  via  receptor  mediated  
endocytosis,  the  anti  FR  antibodies  and  conjugates  of  folic  acid  can  be  up taken  by  
cancer  cells.  So  the  FR  alpha  is  used  as  a  marker  in  cancer  and  beta  for  inflammatory  
diseases  and  myeloid  leukemia.  Thus  FR  targeting  agents  find  a  good  potential  for  
treatment  of  range  of  diseases.[5] 
When  the  stability  and  structure  of  folate  binding  protein  FBP  from  cow's  whey  was  
studied,  it  was  found  that  it  has  22  %  helix,  5  %  parallel  beta  strand,  17  %  turn  25  %  
ant parallel  beta  strand  and  31  %  random  coil  structure.  Spectroscopy  studies showed  that  
when  folate  binding  occurs  to  folate  binding  protein,  significant  changes  occurs  and  there  
was  a  10  %  decrease  in  the  anti  parallel  beta  strand.  The  magnitude  of  ligand  binding  
was  found  to  be  proportional  to  quenching  of  FBP  tryptophan  fluorescence.  Further  
studies  revealed  that  because  of  the  ligand  binding  to  FBP,  the  folding  stability  of  the  
molecule  was  increased  which  is  by  the  aggregation  of  FBP  caused  by  ligand.  This was 
also confirmed by fluorescence and    spectroscopy.     
8 
 
Current  clinical  trials  show  that  conjugation  with  folate  increases  the  potency  and  reduces  
the  toxicity  of  many  anti    cancer  drugs.  Drugs  that  are  conjugated  to  folic  acid  for  
selective  drug  delivery  are  :  Chemotherapeutic  agents,  Protein  toxins,  Gene  therapy  
Vectors,  Radio  imaging  agents,  Radiotherapeutic  agents,  Liposomes  with  entrapped  drugs,  
immunotherapeutic  agents,  oligonucleotides  (  SiRNA  ),  MRI  contrast  agents.[6] 
Folate  receptors  were  discovered  to  be  over  expressed  on  activated  macrophages  and 
found  to  be  quiescent  on  non  activated  macrophages.  The  cause  and  contribution  of  
activated  macrophages  to  a  number  of  diseases  as  diabetes,  rheumatoid  arthritis,  ischemia,  
sarcoidosis,  psoriasis,  vasculities,  sjogrens  disease,  led  to  studies  which  were  done  to  
develop  folate  conjugated  therapeutic  agents. To  visually  examine  the  delivery  of  folate  
conjugates  into  receptor  bearing  cells,  Susan  Wang  and  Phillip  Low  used  bovine  igG  and  
bovine  ribonuclease.  This  was  conjugated  to  folic  acid  and  15  nm  colloidal  gold  particles  
where  used  to  label  them.   [7] Florescent  probes  were  used  to  label  them  and  then  
conjugated  to  folic  acid.  By  florescent  microscopy  it  was  revealed  that  only  the  
florescent  proteins  which  are  folate  conjugated  were  taken  by  the  folate  receptor  KB  
cells.[1] 
 
After  the  folate  protein  conjugates  are  up taken  by  cancer  cells,  EM  pictures  of  KB  cells  
revealed  the  internalization  of  colloidal  gold  particles  by  KB  cells  through  uncoated  pits.  
Mostly  the  ligands  delivered  by  endocytic  pathways  into  cells  are  internalized  for  
destruction.  That  means,  the  hormones  after  they  transduce  their  signals  or  any  other  
foreign  particle  which  are  harmful  if  they  remain  in  the  cell  are  digested  by  the  
lysosomes.  But  the  folate  conjugates  were  found  to  be  stable  and  functional  after  many  
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hours  of  uptake  by  cancer  cells.  So  the  folic  acid  is  internalized  for  consumption  and  
not  for  destruction.  Thus  it  was  found  that  after  uptake  by  the  FBP,  the  nucleic  acids  
and  proteins  remain  undigested  and  enzymes  retain  their  activities.  [8] 
Upregulation of folate receptors: 
 
Until  late  1991  and  early  1992  the  knowledge  of  FR  up regulation  on  cancer  cells  was  
not  obtained  until  it  was  studied  that  the  FR  was  actually  recognized  by  the  monoclonal  
antibodies  used  in  tissue  biopsies  to  study  cancer  cells. Mainly, two different classes of 
proteins mediate the cellular uptake and absorption of folate [9]. One is the reduced folate carrier 
(RFC) are the transmembrane proteins, which have micro molar affinity to bind with the reduced 
folate. The second class is the folate binding proteins family also called as folate receptor. 
Further  learning  on  the  distribution  of  FR  actually  gave  a  new  approach  to  the  cancer  
research  that  the  FR  is  mainly  restricted  to  malignant  tissues  rather  than  normal  tissues.  
From  then,  FR  was  used  as  a  tool  for  selective  targeting  of  drugs  to  the  cancer  cells.  
This  study  lead  to  the  development  of  folate  linked  cytotoxic  drugs.  When  the  linkage  of  
folate  pseudomonas  exotoxin  (  PE38)  and  folic  acid  was  studied,  it  was  demonstrated  
that  the  effect  of  the  conjugate  was  depending  on  the  type  of  the  bond  between  them.  
With  the  reducible  disulphide  bond  linkage,  maximum  potency  was  observed  and  with  
thioether  bond,  there  was  a  decrease  in  its  potency.  Thus  with  these  demonstrations  it  
was  shown  that  the  cleavable  linker  in  the  folate  targeted  cytotoxic  drug  was  important  
in  the  designs  of  future  conjugated  drug  designs. [10, 11] 
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Imaging of Folate Receptor Tumors: 
 
Imaging  of  folate  receptor  tumors  was  found  to  be  feasible  using  radio  labeled  folate  
conjugates.  The  chelating  agents  that  have  high  affinity  for  γ-emitting  metal  
radionuclide’s  are  used  after  folate  derivatization.  Folate  was  conjugated  with  chelator  
deferroxamine  and  labeled  with  67Ga,  this  was  intravenously  injected  into  mice  with  
xerographic  implants  from  cells  cultured  with  KB.  Thus  high  tumor  selectivity  was  
achieved  by  folate  targeted  imaging  agents.  Studies  show  that  it  helps  in  detecting  the  
size,  location  and  clinical  stage  of  neoplastic  tissue  and  thus  used  in  planning  the  
treatment  strategy  for  cancer. Recent  studies  showed  that  folate  targeted  liposomes  are  
being  effectively  used  for  gene  therapy. [11] The  gene  therapy  agents  commonly  used  are  
expression  plasmids  and  antisense  oligonucleotides.  Their  uses  are  limited  because  of  
their  low  physiological  stability,  and  lack  of  tissue  specificity.  Because  of  these  
disadvantages  ,  these  macromolecules  are  being  taken  into  consideration  to  enhance  their  
stability  and  permeability.  To  protect  the  antisense  oligonucleotides  from  nuclease  
digestion,  folate  targeted  liposomes  are  used  which  also  enhances  their  intracellular  
delivery.  Treatment  of  KB  cells  with  free  antisense  oligos  and  antisense  oligos  
encapsulated  in  folate  liposomes  showed  that  free  oligos  had  barely  growth  inhibition  and  
no  significant  changes.  But  with  the  use  of  folate  PEG  liposomes  ,  there  was  measurable  
growth  inhibition  and  abnormalities  in  the  morphology.  Further  studies  proved  that  
encapsulated  oligos  showed  complete  suppression  of  growth  factor  receptor  thus  indicating  
the  efficiency  and  non  destructive  delivery  of  encapsulated  oligos  into  cancer  cells. [12] 
Because  of  the  inefficient  escape  of  plasmids  from  the  cell's  endosomal  compartments  ,  
the  use  folate  targeted  carriers    has  been  limited  in  the  tumor  specific  delivery  of  
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vectors.  To  overcome  this  issue,  studies  were  conducted  to  modify  the  liposomes  such  
that  they  deliver  their  effects  only  after  entering  the  target  cell  endosomes.  One  approach  
which  was  used  by  developing  a  ph  sensitive  lipid  composition  . This becomes   lysogenic 
after entering into acidic endosomes. [13] The other approach uses the fusogenic oligopeptide.  
This initiates membrane fusion by changing the conformation.  By  testing  cytosine  arabinoside,  
an  anticancer  drug  in  folate  liposomal  preparation,  the  effectiveness  was  found  to  
increase  by  folate  targeting.  The  potency  was  found  to  increase  further  by  constructing  
ph  sensitive  diplasmalogen.  Thus  the  use  of  pH  sensitive  lipid  design  and  peptide  will  
have  great  impact  on  efficiency  of  expression.  Furthermore,  the  use of conjugated  
nanoparticles  with  folic  acid  proved  to  have  targeted  effect  in  treatment  of  cancer.  This  
effect  was  shown  by  particles  which  have  biodegradable  polymer  core  and  mixed  lipid  
monolayer  shell.  Docetaxel  when  used  with  the  nanoparticles  showed  a  markable  increase  
in  the  cytotoxic  effect. Furthermore  another  advantage  of  using  the  drug  with  
nanoparticles  is  that  the  targeting  effect  can  be  controlled  and  adjusted  by  lipid  
component  ratio  of  mixed  lipid  monolayer.  This  targeting  efficiency  of  lipid  monolayer  
was  proved  by  fluorescent  microscopy  which  shows  that  controlled  and  targeted  delivery  
is  achieved  by  folic  acid  conjugated  nanoparticles  which  can  be  the  drug  delivery  system  
where  the  targeting  effect  is  precisely  controlled.[14] 
 
Folate Conjugates: 
 
Another  type  of  folate  nanoconjugates  were  synthesized  which  were  found  to  be  magneto  
fluorescent  and  cancer  specific  targeting  folate  conjugates  [15] . These  particles  were  
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designed  with  pendant  groups  (  amino,  carboxyl  )  on  their  surface  with  o  -  
carboxymethyl  chitosan  (  OCMC).  These  groups  facilitate  in    covalent  attachment  of  
rhodamine  isothiocyanate  (  RITC)  which  is  a  fluorescent  dye.  the  magneto  fluorescent  
nanoparticles  were  conjugated  on  to  the  aminated  derivative  of  folic  acid.  These  magneto  
fluorescent  conjugates  were  found  to  be  biocompatible,  with  good  dispersibility  .  In  the  
presence  of  external  magnetic  field  they  were  found  to  have  specific  magnetic  properties. 
Further  studies  were  done  using  folate  over  expressed  (  HeLa)  and  normal  cells.  It  was  
proved that  the  uptake  of  these  nanoparticles  folate  conjugates  is  more  in  cancer  cells  
than  in  normal  cells.[10] 
 
CdHgTe  folate  conjugates  :    These    were  found  to  have  stability  ,  optical  spectra  and  
cancer  cell  targeting  characteristics.  They  were  prepared  by  covalent  conjugation  of  folic  
acid  and  CDHgTe  quantum  dots.  The  fluorescent  wavelength  of  CdHgTe  folate  
conjugates  was  found  to  be  790  nm  .  The  long  and  continuous  fluorescence  imaging  was  
achieved  by  these  conjugates  because  of  their  fluorescence  stability.  The  bio  distributions  
of  these  conjugates  were  studied  in vivo  in  S180  tumor  mouse  which  proved  their  tumor  
targeting  efficiency.  These  CdHgTe  folate  conjugates  can  be  used  for  monitoring  and  
imaging  because  of  their  high  fluorescence  intensity.  The  intracellular  delivery  against  
folate  receptor  is  enhanced  by  heparin-PEG-folate  (H-PEG-F). In this, the folate is 
conjugated with succinylated heparin.  Since  it  is  has  amphiphilic  property  as  it  has  
covalent  bonding,  it  can  be  used  with  hydrophobic  drug  such  as  taxol.  Nanoparticles  
made  with  the  drug  and  H-PEG-F  have  the  drug  in  the  core  with  folate  on  its  surface.  
[16] By  UV  technique,  the  quantitative  analysis  of  folate  and  taxol  is  studied  and  NMR  
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technique,  the  particles  are  characterized  for  their  structure.  Size  of  the  nanoparticles  is  
studied  by  field  emission  scanning  electron  microscopy  (  FESEM  )  .  When  these  
nanoparticles  were  studied  for  their  effect,  it  was  shown  that  the  cellular  uptake  of  the  
carrier  by  KB-3-1  cells  which  are  the  folate  receptor  over  expressing  cell  line  is  more  
than  for  the  folate  receptor  deficiency  cell  line.    With  the  help  of  flow  cytometry,  it  
was  depicted  that  when  the  KB-3-1  cells  were  treated  with  nanoparticles  ,  the  G2/M  
phase  of  cell  cycle  was  found  to  be  arrested.  This  effect  it  similar  to  the  inhibition  
mechanism  of  taxol.  With  the  help  of  these  folate  conjugated  nanoparticles  various  
therapeutic  agents  can  be  used  for  cancer  cell  targeted  delivery.    The  conjugation  of  
folic  acid  to  chitosan  molecules  was  done  via  the  gamma  carboxyl  moiety.  This  helps  in  
retaining  a  high  affinity  for  folate  receptor  over  expression  in  colorectal  cancer  cells.  For  
the  detection  of  colorectal  cancer  ,  folic  acid  conjugated  with  chitosan  nanoparticles  is  
used  for  carrying  5-  amino  aevulinic  acid  (5-ALA).  Folic  acid  -chitosan  conjugates  were  
prepared  and  then  5-ALA  was  loaded  to  form  fCNA  nanoparticles.  When  these  
nanoparticles  were  used  to  study  their  uptake,  it  was  found  that  the  fCNA  particles  were  
taken  up  more  easily  by  caco-2  cell  lines  and  HT29  cells.  Since  the  colorectal  cancer  is  
often  undetected  with  current  colonoscopy  practices  it  is  the  major  leading  cause  of  
malignant  death.  With  the  use  of  these  folic  acid  -chitosan  conjugates  the  colorectal  
specific  delivery  of  5-  ALA  appears  to  be  an  ideal  option  in  the  endoscopic  detection  of  
colorectal  cancer. [17] 
Folate receptor beta   expressed by tumor-associated macrophages: 
According  to  their  response  to  pro-th1/proinflammatory  stimuli  or  pro-Th2/anti-
inflammatory  stimuli  ,activated  macrophages  are  grouped  functionally.  The  folate  receptor  
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beta  (FR  beta)  which  is  encoded  by  FOLR2  is  expressed  with  increased  folate  uptake  
ability. M-CSF  promotes  the  folate  uptake  ability  of  macrophages  and  thus  indicates  a  
link  between  M2  polarization  and  FR  beta  expression. The  tumor  associated  macrophages  
(TAM)  exhibits  M2  like  functional  profile  and  helps  in  detecting  the  FR  beta  expression.  
[5] The  expression  of  FR  beta  mediates  folate  uptake  by  CD68(+)  CD14(+)  CD163(+).  
The  ascetic  fluid  of  the  tumor  and  the  medium  of  tumor  cell  induces  the  expression  in  
an  M-CSF  dependent  manner.  The  high  degree  of  macrophage  infiltration  is  usually  
associated  with  tumor  associated  macrophages  (  TAMs)  found  in  glioblastomas.  In  an  
experiment  conducted  to  study  the  expression  of  folate  receptors,  a  rat  C6  glioma  
subcutaneously  implanted  in  nude  mice,  recombinant  immunotoxin  was  produced  to  target  
TAMs  with  FR  beta  expression.  It  consisted  of  immunoglobulin  heavy  and  light  chain  
portions  and  pseudomonas  exotoxin  A.  C6  glioma  xenografts  when  injected  with  the  
immunotoxin  was  shown  to  deplete  TAMs  and  thus  inhibiting  the  growth  of  the  tumor.  
FR  beta  expressing  macrophages  targeted  by  the  immunotoxin  provides  a  good  
therapeutic  tool  in  the  treatment  of  glioblastomas.  These  studies  indicate  that  FR  beta  is  
a  marker  in  M2  regulatory  macrophage  polarization.[4] 
Folate Quantum Dots: 
 
The  folate  quantum  dots  were  synthesized  with  folate  poly  ethylene  glycol  conjugates  
and  polyamidoamine  (PAMAM  )  . [18] These  are  useful  in  the  design  and  development  
for  bio  imaging  and  optical  imaging  of  cancer  cells.  The  CdSe/ZnS  dots  were  found  to  
encapsulate  the  ligand  by  ligand  exchange  reactions.  These  ligand  exchanged  QDs  were  
found  to  target  the  tumor  cells  because  of  membrane  expression  of  folate  receptors.  The  
cellular  uptake  of  FPP  coated  QDs  is  more  in  HeLa  cells  when  compared  to  QDs  
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without  folate.  The  FPP  quantum  dots  show  slow  endosomal  escape  after  binding  to  the  
tumor  cell  surface.  After  entering  ,  they  release  into  the  tumor  cells.[19] 
The  anticancer  drug  Irinotecan  is  used  in  the  treatment  of  colon  cancer  but  its  active  
metabolite  ,  SN-38  (7-ethyl-10-hydroxycamptothecin)  which  is  very  hydrophobic  was  
found  to  be  more  cytotoxic  than  the  original  drug.  To  improve  the  stability  and  
solubility  SN  38  was  formulated  into  folate  nanoparticles.  These  were  produced  by  
emulsification  of  poly  lactide  co  glycolide  polyethylene  glycol  with  SN  -38  .  By  
coupling  of  PLGA-PEG-NH  diblock  copolymer  with  folic  acid,  the  folate-  conjugated  di  
block  copolymer  were  synthesized. When  these  conjugates  were  studied  against  HT-29  
cancer  cells,  it  was  shown  that  the  S38  loaded  particles  have  strong  cytotoxic  effects  
than  with  the  control  . [20] With  this  study  it  was  demonstrated  that  for  the  hydrophilic  
drugs,  folate  conjugation  is  the  efficient  way  for  to  increase  the  cytotoxicity  of  the  drug.  
Folic  acid  conjugation  was  done  to  bovine  serum  albumin  nanoparticles  (BSANP).  Into 
the folate conjugated albumin nanoparticles, mitoxantrone was incorporated. These  
nanoparticles  were  used  to  target  SKOv3  cells  where  the  folate  receptors  are  over  
expressed.  Incorporation  of  mitoxantrone  to  the  nanoparticles  lead  to  the  cytotoxic  
activity  of  MTO-BSANP-folate.  This  activity  was  quantitatively  determined  and  was  
found  to  be  more  when  compared  to  just  the  MTO-BSANP  and  MTO  solution  in vivo.  
Thus  it  was  shown  that  folate  conjugated  BSANP  have  good  potential  in  the  cancer  
chemotherapy. [9] 
Glutathione modified Gold   Nanoparticles: 
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Because  of  the  over  expression  of  folate  receptors  on  variety  of  cancers,  the  therapeutic  
agents  and  folate  linked  imaging  can  be  targeted  to  FR  expressing  tumors.  In  this  way,  
uptake  by  the  healthy  tissues  can  be  avoided  which  express  very  less  FR.  Using  gold  
nano  particles,  the  drug  glutathione  was  modified  to  form  GSH-  capped  GNPs. These 
particles have carboxyl group on their surface [20] .Though  the  reaction  of  amino  group  on  
folic  acid,  these  particles  were  conjugated  .In  aqueous  solution  the  folic  acid  conjugated  
gold  nanoparticles  were  found  to  be  stable. By  transmission  electron  microscopy  it  was  
confirmed  that  the  FA-GSH-GNPs  were  up taken  by  the  human  cervices  carcinoma  cells  
which  showed  high  level  of  folate  receptor  expression.  In  cells  which  lack  folate  
receptor,  no  uptake  was  seen  .  The  relative  absorbance  of  the  supernatant  was  measured  
with  HeLa  cells  incubated  with  FA-GSH-GNPs.  The  HeLa  cells  were  detection  with  the  
detection  limit  of  10(2)  cells  /mL  by  spectroscopic  method.      As  in  the  case  of  
methotrexate,  which  is  used  in  the  treatment  of  rheumatoid  arthritis,  the  targeting  
mechanism  plays  an  important  role  in  the  treatment.  MTX  because  of  it  plasma  protein  
binding  is  responsible  for  its  effective  distribution  in  the  body.  in  RA  patients,  the  
expression  of  folate  receptor  β  (FR-β)  is  found  to  be  high  on  synovial  macrophages. This 
mediates in high uptake of MTX in the cells.  Such  studies  conclude  the  FR-β  specific  
therapy  and  is  being  employed  for  drugs  other  than  MTX.[6] 
 
Detection of folate binding protein by optical biosensor analysis: 
 
Biosensor is based on SPR technique. It is the surface plasma resonance technique.  In SPR 
system, there is a laser light source which produces light, detector, gold surface and a glass 
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prism. The incident polarized light under goes total internal reflection and this is configured at 
the interface. The electromagnetic field which is generated gets penetrated into the metal and 
then it transfers some of its energy to its valence electrons. This produces charge density waves 
which are known as Surface plasmons[5]. When there is any association or dissociation at the 
sensor surface, it is recorded as a plot of change in refractive index with time.[21] 
 
Detection of folate binding protein in milk: 
 
In early 1960's Ghitis observed that there is a presence of a macro molecular factor in milk which 
is heat labile. This factor prevented the adsorption of milk folate onto the activated charcoal. 
Furthermore observations lead to the conclusion that the high affinity folate binding protein is 
present in bovine milk which prevents the milk from adsorption on to charcoal. This FBP was 
found to contain 222 amino acids.[22, 23] 
The interactions of folate and FBP are essential for study of metabolism of folate and the 
bioavailability of folate. In the indirect technique for FBP quantification, the folate content was 
measured after the unbound folate which is excessive is absorbed onto charcoal. The direct 
technique for determination of FBP was ELISA. [24] This is done by a antibody which is raised 
against the FBP in milk. These two techniques do not determine the complexation of FBP with 
folate. To distinguish the free apo form from the complexed holo form, a technique was 
discovered which was called the Surface Plasma resonance (SPR). The SPR technique works by 
measuring the refractive index near the surface. By this method, the apo form of the protein can 
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be easily measured.  The most commonly used SPR system is the Biacore system by GE health 
care Sweden.[23] 
 
Analysis with Biacore system: 
The components of Biacore system are: interchangeable sensor chip, micro fluidic sample 
handling system and SPR detector. The sensor chip consists of a glass slide which is plated with 
gold. A coupling matrix is used which covers the gold film .This coupling matrix is important 
because it reduces the mobilization capacity of the molecules and hence for characteristics of the 
surface. The non specific absorption of proteins is prevented because of the hydrophilic property 
of the matrix. The interacting partners are immobilized on to the sensor chip surface and the 
aqueous samples are injected onto this surface. To control the flow of buffer over the sensor 
surface, IFC i.e., integrated micro -fluidic cartridge is used which gives a continuous flow [25] 
.The detector detects the binding of interactant and is quantified in real time. The interaction is 
detected when analyte which is the binding partner binds to the immobilized molecule on the 
sensor surface. The coupling of activated dextran to the amine group was not possible because 
for the binding to occur, a ring system is important. So the sample folic acid which was used 
were coupled on the sensor surface to the amino groups were in their hydroxysuccinimidyl 
forms. Because of the amine coupling, the FBP is immobilized on the sensor surface.  When this 
binding takes place, there is an increase in the mass at the surface and this result in change in 
refractive index. This change is measured real time and a graph is plotted with resonance units or 
response with time. This plot with Resonance Units and time is called a Sensogram.  The 
sensogram gives information about the interaction rate (association or dissociation) through 
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which the concentration of analyte can be known, the affinity constants are obtained from the 
binding level information.[25] 
 
Concentration Analysis: 
In this assay, only the binding which is specific to the two samples is studied. To determine the 
amount of analyte bound, the rate at which the analyte binding occurs at the beginning when the 
sample is injected can be taken into account .The other approach is to measure the total amount 
of analyte which has binded after the whole sample injection. The rate of binding is directly 
proportional to the concentration of analyte when the association of the samples is dependent on 
the rate at which the samples are transported. [26] 
This method was shown to be in compliance with ELISA method.  It was also found that at FBP 
concentration of 0.38µg/mL, the repeatability (CV) was found to be 1.2 - 3.6 % within assay for 
3 different days. This method is based on interaction of the PGA and FBP, so the folate which is 
endogenous must be removed to estimate the total FBP content because it can interfere with the 
assay method. For this assay to be done, the presence of pteridine moiety of folate was important 
for the interaction to occur. [26] 
From the data obtained by the interaction of the analyte and the ligand at the sensor surface, the 
association, dissociation and the equilibrium constants can be analyzed. By this SPR technique, 
the free and the apo form of FBP can be differentiated so that the effect of FBP on the stability of 
folate can be known. For the study of the specific interactions of protein- vitamin, this modern 
technique is highly useful.[8, 27] 
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Detection of folate binding protein with Megalin: 
 
Megalin is a member of low density lipoprotein receptor family. It is a multiligand endocytic 
receptor which is mainly expressed in proximal tubule of kidney, intestine and other absorptive 
epithelia.[27] This megalin has an affinity to bind to the FBP present in milk. In early 2000, the 
research conducted on uptake of FBP by megalin showed that megalin has high affinity to bind 
to the FBP but it cannot bind to the low density lipoprotein receptor protein. When this study was 
done on immortalized rat yolk sac cells, it showed that the 125I- labeled FBP was up taken by 
the megalin and this uptake was inhibited by antimegalin antibodies and also by the receptor 
associated proteins. When 125-I labeled FBP was injected into proximal tubule in vivo, there 
was endocytotic uptake in the renal tubules. Since the human body cannot synthesize folate, the 
up regulation of folate is very important in the intestines.[14] 
 
Binding of FBP and Megalin:  
The binding of bovine milk apo FBP to immobilized rabbit megalin was shown by SPR 
techniques. This binding was also observed with 5-methyltetrahydrofolate (5-MTHF), or 
methotrexate. Autoradiography techniques were used to confirm the binding of FBP to megalin 
in proximal tubule brush border membranes of kidney. On incubation with 125I labeled bovine 
milk FBP, autoradiographic grains were shown to be accumulated along the proximal tubule 
which was inhibited by incubation with receptor associated protein.  [8]This receptor associated 
protein is a known inhibitor of megalin. It inhibits the ligands uptake by megalin, thus it shows 
that megalin has a very specific binding capacity [8] .The uptake of FBP by megalin was 
calculated as the sum of cell associated, degraded and non trichloroacetic acid precipitable label. 
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Detection of folate binding protein by Quartz Crystal Microbalance Sensor: 
Because of the fact that FBP are present in both the normal and metastatic states, radio 
immunoassays are employed for their detection. These involve the use of radioactive labels 
which are hazardous and also the analysis time is long for the detection. To overcome this, a 
quartz crystal microbalance method (QCM) was discovered in 2006 which allows the recognition 
of antigen antibody, assess the surface layer phenomenon and also the capture of viral and 
bacterial cell. For  the  detection  of  folate  binding  protein, a  quartz  crystal  microbalance  
biosensor was developed.[5]  Detection  limit  of  30  nm  was  achieved  with  Au  coated  
quartz  sensor  absorbed  with  simple  folate  BSA  conjugate.  At  concentrations  higher  than  
1  micro molar  in  excess  of  folic  acid,  the  binding  of  FBP  to  sensor  surface  are  blocked.  
This showed the specificity of folate FBP interaction. When there is an association or 
dissociation of protein to the surface of the quartz sensor, change in the mass of the crystal 
occurs.  This results in the increase or decrease in the frequency. When the analyte gets captured 
on the crystal surface, the effective surfaces mass increases, and thus the resonance frequency 
decreases. This decrease in the frequency is because of the binding of the proteins to the quartz 
surface.  Since the molecular weight of the analyte protein could be very small, some secondary 
ligands such as iron or gold particles are employed. These ligands increase the sensitivity by 
increase in the mass of the analyte binding to the surface. Thus with the use of quartz crystal 
microbalance analysis, the sensitivity of the assay was increased significantly.[7, 28] 
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The basic operation of QSM described by Sauerbrey is given as   
(∆mQCM )  = - (CQCM/n) ∆f   where CQCM (17.7 ng cm-2 Hz-1) is the mass sensitivity 
constant and n (1, 3 ...) is the overtone number, ∆ m is the mass change, and ∆f is the change in 
resonance frequency. [5] 
 
 
Imaging Studies: 
In  early  2005  ,further  studies  were  in  the  field  of    the  in vivo  imaging  of  arthritis  which  
is  the  inflammatory  joint  disease  was  done  using  a  lipopolysacharide  intra  articular  
injection  model  and  a  KRN  transgenic  mice  serum  induction  mouse  model  for  the  testing  
of  a  recently  developed  near  infra  red  fluorescence  labeled  folate  probe  (  NIR2  -folate) 
[29] .Arthritis  is  characterized  by  active  macrophages  with  over  expressed  FR  receptors.    
In  the  joints  with  lipopolysaccharide  treated  and  the  control  joints,  the  fluorescence  signal  
intensity  of  free  and  NIR2  folate  was  compared.    At  the  NIR2  folate  probe, the  
fluorescence  signal  intensity  was  found  to  be  higher  than  control  normal  joints  .After  the  
transfer  of  serum,  the  NIR2  folate  was  applied  at  different  time  points  in  the  KRN  
serum  transfer  model.  After  the  transfer  of  arthritogenic  antibody  transfer,  the  inflamed  
joints  were  detected  after  30  hours  and  shown  to  have  an  increase  of  1.8  fold  in  the  
intensity  of  the  signal.  Thus  it  was  concluded  in  this  study  that  using  a  fluorescent  
probe,  the  in vivo  detection  of  arthritis  could  be  done  and  hence  with  this  receptor  
targeting  method,  improved  arthritis  diagnosis  can  be  facilitated.[30] 
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Conclusion: 
As there is a vast potential for folate targeting anti cancer drugs, the study and detection of folate 
binding protein provides an essential tool for diagnosis and monitoring the therapy for treatment 
of cancer. These folate delivery systems are essential to establish the level of folate receptors 
required for the cancer cells to be treated by the folate targeting drugs. By various SPR 
techniques, a simple fast and robust method was developed to distinguish the apo and the holo 
forms of FBP. The future studies in this field are the use of nanomechanical sensors which can 
further explore the detection capacity of biosensors for eg, in relation to the work done by Dr 
Henne by using Quartz crystal microbalance sensor, the use of nanomechanical sensors gives a 
new approach to the folate targeting of the drugs. Applications and development of various other 
cantilever based sensors is presently being studied by the International Workshop on 
Nanomechanical Sensors. 
 
FIGURES: 
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Figure 1: Structure of folic acid [4] 
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Figure 2: Folate receptor mediated endocytosis [3] 
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 Figure 3: Folic acid Expression [14] 
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                                                            BIACORE AB BIACORE  Technology  Handbook. (1998). 
Figure 4: Surface plasmon resonance (SPR) biosensor principle. [31] 
 
 
26 
 
 
 
                                                                 Biosensors and Bioelectronics,Volume 26, Issue 9, May 2005 
Figure 5: Overview of the basic interactions at the biosensor surface. [31] 
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                                                                                           Biacore T100 instrument handbook 
Figure 6: Sensorgram.[31] 
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                                                                                 W. Henne, Analytical Chem 2006. 
 
Figure 7: Sensor surface functionalization for the detection of folate binding protein. [5]  
(a)Folate BSA is adsorbed on the QCM gold sensor surface and used as a receptor to 
capture FBP. (b) Signal enhancement is obtained by addition of anti-FBP antibody, 
followed by subsequent protein-A-coated gold nanospheres. (c) Structure of folic 
acid.[20] 
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Figure 8 : Quartz Crystal Microbalance Sensor  
 
 
 
 
 
 
                                                   Nature Reviews Molecular Cell Biology 3, 258-268 (April 2002) 
Figure 9: Structure of Megalin featuring regions containing pathogenic epitopes in Heymann 
Nephritis.[1] 
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Figure 10: Autoradiography showing RAP-inhibitable binding of soluble 125I-labeled FBP to 
proximal tubules of rat kidney cortex [1] 
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                                                 H.Birn,Jan Holm. FEBS Journal 272 (2005) 
 
 
Figure 11: Uptake of 125I-labeled bovine milk FBP microinjected into rat nephrons in vivo. 
Uptake of 125I-labeled FBP is visualized by autoradiography on sections from fixed kidney 
cortex. Grains are located over proximal tubule profiles.[1] 
 
 
 
 
 
  
                                                               Arthritis Res Ther. 2005;7(2): R310-7. Epub 2005 Jan 14. 
 
Figure 12: Early detection of the inflammatory joint by NIR2-folate.  
 (a)  White-light image showed no remarkable swelling at bilateral paws. (b)  Merged  near-
infrared  fluorescent  signal  with  a  white-light  image  showed  increase  fluorescence  signal  
intensity  at  the  dorsal  aspect  of  the  right  wrist,  which  has  a  1.8-fold  increase  compared  
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with  the  left  wrist.  (c)  H&E-stain  histology  of  the  right  wrist  showed  polymorphonuclear  
cell  infiltration  at  the  dorsal  aspect  of  the  right  wrist  (arrow).   
 (d)  Histology  of  the  left  wrist  showed  no  remarkable  inflammatory  cell  infiltration.   (e)  
Immunohistochemistry  of  the  right  wrist  showed  Mac-3-positive  cell  infiltration  at  sub 
synovial  tissues. [32, 33] 
 
 
 
 
 
 
                                     Arthritis Res Ther. 2005;7(2): R310-7. Epub 2005 Jan 14. 
 
Figure 13: Establishment of the KRN serum transfer model. [7] 
(a) Discoloration and swelling (arrow) of the right third proximal interphalangeal joint is noted in 
a healthy C57BL/6 mouse 4 days after KRN serum transfer. (b) Near-infrared fluorescent 
imaging of the right paw showed increase fluorescence signal intensity at the inflammatory joint 
(enhancement ratio = 1.9). (c) Correlated H&E-stain section showed abundant inflammatory 
cells infiltration with pannus-like formation. (d) Immunoperoxidase staining of Mac-3. Mac-3-
positive cell infiltration among polymorphonuclear cells was noted in the pannus.[34] 
 
 
 
 
 
 
 
                
                
33 
 
              
                         Arthritis Res Ther. 2005;7(2): R310-7. Epub 2005 Jan 14. 
 
Figure 14 :In vivo near-infrared fluorescent (NIRF) imaging of inflammatory joints in the 
lipopolysaccharide (LPS) induction model [35]  
The NIR2-folate probe was intravenously injected 2 days after LPS intra-articular injection. (a) 
White-light images obtained 48 hours after intra-articular LPS injection at the right ankle joint; 
soft tissue swelling was noted at the affected joint. (b) NIRF images obtained 24 hours after 
NIR2-folate injection. (c) A merged NIRF signal with a white-light image showing specific 
increased fluorescence signal intensity at the affected joint. (d) H&E-stain section of the right 
ankle joint showing abundant inflammatory cell infiltration at sub synovial tissues. (e) NIRF 
images of a longitudinal section of the LPS-treated ankles.[34] 
 
 
 
 
                  
                          
 
                                                              Arthritis Res Ther. 2005;7(2): R310-7. Epub 2005 Jan 14. 
Figure 15: Immunoperoxidase staining  
(a) Mac-3 and (b) folate receptor (FR) at an arthritic ankle 72 hours after lipopolysaccharide 
induction. The Mac-3-positive and FR-positive cells morphologically correlated well in adjacent 
tissue sections. [7] 
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